Cargando…
Effect of spironolactone on the progression of coronary calcification in peritoneal dialysis patients: a pilot study
INTRODUCTION: There is evidence that aldosterone plays a role in the pathogenesis of vascular calcification. The aim of this study was to evaluate the effect of spironolactone, a mineralocorticoid receptor antagonist, on the progression of coronary calcification (CC) in peritoneal dialysis patients...
Autores principales: | Gueiros, Ana Paula Santana, Gueiros, José Edevanilson de Barros, Nóbrega, Karina Tavares, Calado, Eveline Barros, da Matta, Marina Cadena, Torres, Leuridan Cavalcante, Souza, Alex Sandro Rolland, Casarini, Dulce Elena, de Carvalho, Aluizio Barbosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Nefrologia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788848/ https://www.ncbi.nlm.nih.gov/pubmed/31419271 http://dx.doi.org/10.1590/2175-8239-JBN-2019-0009 |
Ejemplares similares
-
Adynamic bone disease
por: Gueiros, Ana Paula Santana, et al.
Publicado: (2021) -
Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients
por: Langote, Amit, et al.
Publicado: (2017) -
Mannheim’s peritonitis index in the prediction of postoperative outcome of peritonitis
por: GUEIROS, LAÍS DOS SANTOS, et al.
Publicado: (2022) -
Calcific Uremic Arteriolopathy in Peritoneal Dialysis Populations
por: New, Nicholas, et al.
Publicado: (2011) -
Vascular and Valvular Calcification in Chronic Peritoneal Dialysis Patients
por: Wang, Angela Yee-Moon
Publicado: (2011)